White House aide Dr. Heidi Overton nominated to lead FDA
President Donald Trump announced Wednesday the nomination of Dr. Heidi Overton, a White House aide, to lead the Food and Drug Administration. The nomination requires Senate confirmation.
Dr. Heidi Overton, a senior White House aide, has been nominated to lead the Food and Drug Administration (FDA), President Donald Trump announced Wednesday. Overton, a medical doctor and deputy director of the White House Domestic Policy Council, has been a key figure in the administration's health initiatives.
The nomination follows the resignation of former FDA head Dr. Marty Makary in May. Makary's tenure left unfinished projects related to issues such as ultra-processed foods, antidepressants, and COVID-19 vaccines.
The new FDA commissioner will face the challenge of balancing competing priorities, including presidential directives, traditional Republican deregulation interests, and Health Secretary Robert F. Kennedy Jr.'s public health agenda. Overton previously served as chief policy officer at the conservative America First Policy Institute.
Overton is expected to advance the administration's health priorities, including lowering drug prices and accelerating innovation. However, her nomination faces a confirmation process in a narrowly Republican-controlled Senate. Her stance on abortion pills and potential changes to FDA regulations are likely to be points of discussion during her confirmation hearings.